Efficacy Of Tocilizumab On Critical Intensive Care Unit COVID-19 Patients: Retrospective Study Among Egyptian Armed Forces Hospitals. - Egyptian Knowledge Bank - troweb

326374

Efficacy Of Tocilizumab On Critical Intensive Care Unit COVID-19 Patients: Retrospective Study Among Egyptian Armed Forces Hospitals.

Article

Last updated: 05 Jan 2025

Overview Similar Items

Article

Efficacy and Safety of Tocilizumab in COVID-19 Patients: Retrospective Study

Article

Clinical and Laboratory Predictors for ICU Admission ‎among COVID-19 Infected Egyptian Patients, A ‎multi-Center Study ‎

Article

Inflammatory changes in Covid19 patients and role of tocilizumab

Article

Clinical and Hematological Characteristics of COVID- 19 at Presentation: Egyptian Multicenter Descriptive Study

Article

Outcome Predictors for ICU Admitted Critically Ill Covid-19 Patients in Fayoum University Hospitals

Article

Interleukin-5, Interleukin-6 and Eosinophils in COVID-19 Egyptian Patients: Potential Clues for Prognosis and Immunotherapy

Article

The clinical outcome of Tocilizumab in the treatment of elderly patients with severe COVID-19 pneumonia

Article

OUTCOMES OF COVID-19 IN EGYPTIAN PATIENTS

Article

The COVID-19 and iron-repertoire in an observational cross-sectional analytical study of Egyptian patients.

Article

Do CRP levels predict severity in COVID-19 hospitalized Egyptian patients?